SLNO
Soleno Therapeutics Inc
NASDAQ: SLNO · HEALTHCARE · BIOTECHNOLOGY
$52.78
+0.04% today
Updated 2026-04-29
Market cap
$2.73B
P/E ratio
135.33
P/S ratio
14.34x
EPS (TTM)
$0.39
Dividend yield
—
52W range
$29 – $90
Volume
3.8M
Soleno Therapeutics Inc (SLNO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
11.00%
Operating margin
44.10%
ROE
6.01%
ROA
2.09%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-6.48M | — | — | — |
| 2013 | $3.00M | $-3.71M | 100.00% | -28.23% | -123.57% |
| 2014 | $0.00 | $-13.87M | — | — | — |
| 2015 | $387555.00 | $-15.91M | 9.00% | -3,137.55% | -4,104.85% |
| 2016 | $1.45M | $-12.07M | -4.03% | -938.12% | -831.63% |
| 2017 | $-1.55B | $-15.67M | 100.10% | 0.78% | 1.01% |
| 2018 | $0.00 | $-13.34M | — | — | — |
| 2019 | $0.00 | $-30.77M | — | — | — |
| 2020 | $0.00 | $-24.64M | — | — | — |
| 2021 | $0.00 | $-30.91M | — | — | — |
| 2022 | $0.00 | $-24.07M | — | — | — |
| 2023 | $0.00 | $-38.99M | — | — | — |
| 2024 | $0.00 | $-175.85M | — | — | — |
| 2025 | $190.41M | $20.89M | 98.58% | 7.85% | 10.97% |